At-Home HPV test kits could boost cervical cancer screening in Hard-to-Reach women

NCT ID NCT04716127

Completed Prevention Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether offering a vaginal self-sampling kit directly to women aged 50-65 who had not had a cervical smear in over three years would increase screening participation. Women received a kit to use at home and mail to a lab for HPV testing. The goal was to see how many accepted the kit and completed the test, with a focus on reaching underserved populations in southern France.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: vaginal self-sampling kit for HPV testing
What this could lead to: If successful, this approach could increase cervical cancer screening rates among women who currently avoid it, helping catch the disease earlier.
What could go wrong: This is a completed behavioral study, not a treatment trial. It tests a screening method, not a cure, and results may not apply to other regions or age groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervix disorder human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HUMAN PAPILLOMA VIRUS UTERINE CERVICAL DISEASE

Contacts and locations

Locations

Arnaud de Villeneuve Hospital, clinical trials Department

Montpellier, Herault, 34295, France
Mammobile Hérault

Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.